Measuring bladder permeability with MRI using a novel contrast agent formulation
Ended Project Grant Awarded Last action
- Award ID
- R42DK108397
- Recipient
-
Lipella Pharmaceuticals Inc. UEI JBVNWFNEEV59
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,241,418
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $585,001 | |
| Original award | $656,417 |
Quick answers
Who received award R42DK108397?
R42DK108397 was awarded to Lipella Pharmaceuticals Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 20, 2015.
How much is award R42DK108397 worth?
$1,241,418 has been obligated on R42DK108397.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award